 | • レポートコード：QFJ1-5131 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、先天性好中球減少症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、顆粒球コロニー刺激因子（G-CSF）、抗真菌薬）、用途別市場規模（小売薬局、病院薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・先天性好中球減少症治療の市場動向 ・企業の競争状況、市場シェア ・先天性好中球減少症治療の種類別市場規模と予測2016-2027（抗生物質、顆粒球コロニー刺激因子（G-CSF）、抗真菌薬） ・先天性好中球減少症治療の用途別市場規模と予測2016-2027（小売薬局、病院薬局、オンライン薬局、その他） ・先天性好中球減少症治療の北米市場規模2016-2027（アメリカ、カナダ） ・先天性好中球減少症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・先天性好中球減少症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・先天性好中球減少症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・先天性好中球減少症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Baxter International、Teva Pharmaceutical, Inc.、Amgen、Sanofi、Novartis AG、Teva Pharmaceuticals Industries Ltd.、Biogenomics Limited、Dr. Reddy’s Laboratory Ltd.、Apotex、Intas Pharmaceuticals Ltd.） ・結論 |
Congenital neutropenia occurs when an individual has low levels of neutrophils, a type of white blood cells. Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones such as the vertebrae, ribs, and pelvis. The congenital neutropenia treatment include antibiotics, antifungal drugs and so on.
Market Analysis and Insights: Global Congenital Neutropenia Treatment Market
The global Congenital Neutropenia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Congenital Neutropenia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Congenital Neutropenia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Congenital Neutropenia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Congenital Neutropenia Treatment market.
Global Congenital Neutropenia Treatment Scope and Market Size
Congenital Neutropenia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Congenital Neutropenia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Granulocyte -Colony- Stimulating Factor (G-CSF)
Antifungal Drugs
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Baxter International
Teva Pharmaceutical, Inc.
Amgen
Sanofi
Novartis AG
Teva Pharmaceuticals Industries Ltd.
Biogenomics Limited
Dr. Reddy’s Laboratory Ltd.
Apotex
Intas Pharmaceuticals Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Congenital Neutropenia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Granulocyte -Colony- Stimulating Factor (G-CSF)
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Congenital Neutropenia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Congenital Neutropenia Treatment Market Perspective (2016-2027)
2.2 Congenital Neutropenia Treatment Growth Trends by Regions
2.2.1 Congenital Neutropenia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Congenital Neutropenia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Congenital Neutropenia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Congenital Neutropenia Treatment Industry Dynamic
2.3.1 Congenital Neutropenia Treatment Market Trends
2.3.2 Congenital Neutropenia Treatment Market Drivers
2.3.3 Congenital Neutropenia Treatment Market Challenges
2.3.4 Congenital Neutropenia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Congenital Neutropenia Treatment Players by Revenue
3.1.1 Global Top Congenital Neutropenia Treatment Players by Revenue (2016-2021)
3.1.2 Global Congenital Neutropenia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Congenital Neutropenia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Congenital Neutropenia Treatment Revenue
3.4 Global Congenital Neutropenia Treatment Market Concentration Ratio
3.4.1 Global Congenital Neutropenia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Congenital Neutropenia Treatment Revenue in 2020
3.5 Congenital Neutropenia Treatment Key Players Head office and Area Served
3.6 Key Players Congenital Neutropenia Treatment Product Solution and Service
3.7 Date of Enter into Congenital Neutropenia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Congenital Neutropenia Treatment Breakdown Data by Type
4.1 Global Congenital Neutropenia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Congenital Neutropenia Treatment Forecasted Market Size by Type (2022-2027)
5 Congenital Neutropenia Treatment Breakdown Data by Application
5.1 Global Congenital Neutropenia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Congenital Neutropenia Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Congenital Neutropenia Treatment Market Size (2016-2027)
6.2 North America Congenital Neutropenia Treatment Market Size by Type
6.2.1 North America Congenital Neutropenia Treatment Market Size by Type (2016-2021)
6.2.2 North America Congenital Neutropenia Treatment Market Size by Type (2022-2027)
6.2.3 North America Congenital Neutropenia Treatment Market Size by Type (2016-2027)
6.3 North America Congenital Neutropenia Treatment Market Size by Application
6.3.1 North America Congenital Neutropenia Treatment Market Size by Application (2016-2021)
6.3.2 North America Congenital Neutropenia Treatment Market Size by Application (2022-2027)
6.3.3 North America Congenital Neutropenia Treatment Market Size by Application (2016-2027)
6.4 North America Congenital Neutropenia Treatment Market Size by Country
6.4.1 North America Congenital Neutropenia Treatment Market Size by Country (2016-2021)
6.4.2 North America Congenital Neutropenia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Congenital Neutropenia Treatment Market Size (2016-2027)
7.2 Europe Congenital Neutropenia Treatment Market Size by Type
7.2.1 Europe Congenital Neutropenia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Congenital Neutropenia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Congenital Neutropenia Treatment Market Size by Type (2016-2027)
7.3 Europe Congenital Neutropenia Treatment Market Size by Application
7.3.1 Europe Congenital Neutropenia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Congenital Neutropenia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Congenital Neutropenia Treatment Market Size by Application (2016-2027)
7.4 Europe Congenital Neutropenia Treatment Market Size by Country
7.4.1 Europe Congenital Neutropenia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Congenital Neutropenia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Congenital Neutropenia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type
8.2.1 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application
8.3.1 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Congenital Neutropenia Treatment Market Size by Region
8.4.1 Asia-Pacific Congenital Neutropenia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Congenital Neutropenia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Congenital Neutropenia Treatment Market Size (2016-2027)
9.2 Latin America Congenital Neutropenia Treatment Market Size by Type
9.2.1 Latin America Congenital Neutropenia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Congenital Neutropenia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Congenital Neutropenia Treatment Market Size by Type (2016-2027)
9.3 Latin America Congenital Neutropenia Treatment Market Size by Application
9.3.1 Latin America Congenital Neutropenia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Congenital Neutropenia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Congenital Neutropenia Treatment Market Size by Application (2016-2027)
9.4 Latin America Congenital Neutropenia Treatment Market Size by Country
9.4.1 Latin America Congenital Neutropenia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Congenital Neutropenia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Congenital Neutropenia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type
10.2.1 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application
10.3.1 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Congenital Neutropenia Treatment Market Size by Country
10.4.1 Middle East & Africa Congenital Neutropenia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Congenital Neutropenia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Baxter International
11.1.1 Baxter International Company Details
11.1.2 Baxter International Business Overview
11.1.3 Baxter International Congenital Neutropenia Treatment Introduction
11.1.4 Baxter International Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.1.5 Baxter International Recent Development
11.2 Teva Pharmaceutical, Inc.
11.2.1 Teva Pharmaceutical, Inc. Company Details
11.2.2 Teva Pharmaceutical, Inc. Business Overview
11.2.3 Teva Pharmaceutical, Inc. Congenital Neutropenia Treatment Introduction
11.2.4 Teva Pharmaceutical, Inc. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.2.5 Teva Pharmaceutical, Inc. Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Congenital Neutropenia Treatment Introduction
11.3.4 Amgen Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Congenital Neutropenia Treatment Introduction
11.4.4 Sanofi Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Congenital Neutropenia Treatment Introduction
11.5.4 Novartis AG Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Teva Pharmaceuticals Industries Ltd.
11.6.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.6.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.6.3 Teva Pharmaceuticals Industries Ltd. Congenital Neutropenia Treatment Introduction
11.6.4 Teva Pharmaceuticals Industries Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.6.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.7 Biogenomics Limited
11.7.1 Biogenomics Limited Company Details
11.7.2 Biogenomics Limited Business Overview
11.7.3 Biogenomics Limited Congenital Neutropenia Treatment Introduction
11.7.4 Biogenomics Limited Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.7.5 Biogenomics Limited Recent Development
11.8 Dr. Reddy’s Laboratory Ltd.
11.8.1 Dr. Reddy’s Laboratory Ltd. Company Details
11.8.2 Dr. Reddy’s Laboratory Ltd. Business Overview
11.8.3 Dr. Reddy’s Laboratory Ltd. Congenital Neutropenia Treatment Introduction
11.8.4 Dr. Reddy’s Laboratory Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.8.5 Dr. Reddy’s Laboratory Ltd. Recent Development
11.9 Apotex
11.9.1 Apotex Company Details
11.9.2 Apotex Business Overview
11.9.3 Apotex Congenital Neutropenia Treatment Introduction
11.9.4 Apotex Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.9.5 Apotex Recent Development
11.10 Intas Pharmaceuticals Ltd.
11.10.1 Intas Pharmaceuticals Ltd. Company Details
11.10.2 Intas Pharmaceuticals Ltd. Business Overview
11.10.3 Intas Pharmaceuticals Ltd. Congenital Neutropenia Treatment Introduction
11.10.4 Intas Pharmaceuticals Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021)
11.10.5 Intas Pharmaceuticals Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Congenital Neutropenia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Granulocyte -Colony- Stimulating Factor (G-CSF)
Table 4. Key Players of Antifungal Drugs
Table 5. Global Congenital Neutropenia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Congenital Neutropenia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Congenital Neutropenia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Congenital Neutropenia Treatment Market Share by Regions (2016-2021)
Table 9. Global Congenital Neutropenia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Congenital Neutropenia Treatment Market Share by Regions (2022-2027)
Table 11. Congenital Neutropenia Treatment Market Trends
Table 12. Congenital Neutropenia Treatment Market Drivers
Table 13. Congenital Neutropenia Treatment Market Challenges
Table 14. Congenital Neutropenia Treatment Market Restraints
Table 15. Global Congenital Neutropenia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Congenital Neutropenia Treatment Market Share by Players (2016-2021)
Table 17. Global Top Congenital Neutropenia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Neutropenia Treatment as of 2020)
Table 18. Ranking of Global Top Congenital Neutropenia Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Congenital Neutropenia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Congenital Neutropenia Treatment Product Solution and Service
Table 22. Date of Enter into Congenital Neutropenia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Congenital Neutropenia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Congenital Neutropenia Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Congenital Neutropenia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Congenital Neutropenia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Congenital Neutropenia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Congenital Neutropenia Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Congenital Neutropenia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Congenital Neutropenia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Congenital Neutropenia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Congenital Neutropenia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Congenital Neutropenia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Congenital Neutropenia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Congenital Neutropenia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Congenital Neutropenia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Congenital Neutropenia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Congenital Neutropenia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Congenital Neutropenia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Congenital Neutropenia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Congenital Neutropenia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Congenital Neutropenia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Congenital Neutropenia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Congenital Neutropenia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Congenital Neutropenia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Congenital Neutropenia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Congenital Neutropenia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Congenital Neutropenia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Congenital Neutropenia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Congenital Neutropenia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Congenital Neutropenia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Congenital Neutropenia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Congenital Neutropenia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Congenital Neutropenia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Congenital Neutropenia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Congenital Neutropenia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Baxter International Company Details
Table 63. Baxter International Business Overview
Table 64. Baxter International Congenital Neutropenia Treatment Product
Table 65. Baxter International Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 66. Baxter International Recent Development
Table 67. Teva Pharmaceutical, Inc. Company Details
Table 68. Teva Pharmaceutical, Inc. Business Overview
Table 69. Teva Pharmaceutical, Inc. Congenital Neutropenia Treatment Product
Table 70. Teva Pharmaceutical, Inc. Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 71. Teva Pharmaceutical, Inc. Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Congenital Neutropenia Treatment Product
Table 75. Amgen Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Congenital Neutropenia Treatment Product
Table 80. Sanofi Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Congenital Neutropenia Treatment Product
Table 85. Novartis AG Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Teva Pharmaceuticals Industries Ltd. Company Details
Table 88. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 89. Teva Pharmaceuticals Industries Ltd. Congenital Neutropenia Treatment Product
Table 90. Teva Pharmaceuticals Industries Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 92. Biogenomics Limited Company Details
Table 93. Biogenomics Limited Business Overview
Table 94. Biogenomics Limited Congenital Neutropenia Treatment Product
Table 95. Biogenomics Limited Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 96. Biogenomics Limited Recent Development
Table 97. Dr. Reddy’s Laboratory Ltd. Company Details
Table 98. Dr. Reddy’s Laboratory Ltd. Business Overview
Table 99. Dr. Reddy’s Laboratory Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 100. Dr. Reddy’s Laboratory Ltd. Recent Development
Table 101. Apotex Company Details
Table 102. Apotex Business Overview
Table 103. Apotex Congenital Neutropenia Treatment Product
Table 104. Apotex Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 105. Apotex Recent Development
Table 106. Intas Pharmaceuticals Ltd. Company Details
Table 107. Intas Pharmaceuticals Ltd. Business Overview
Table 108. Intas Pharmaceuticals Ltd. Congenital Neutropenia Treatment Product
Table 109. Intas Pharmaceuticals Ltd. Revenue in Congenital Neutropenia Treatment Business (2016-2021) & (US$ Million)
Table 110. Intas Pharmaceuticals Ltd. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Congenital Neutropenia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Granulocyte -Colony- Stimulating Factor (G-CSF) Features
Figure 4. Antifungal Drugs Features
Figure 5. Global Congenital Neutropenia Treatment Market Share by Application: 2020 VS 2027
Figure 6. Retail Pharmacies Case Studies
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Others Case Studies
Figure 10. Congenital Neutropenia Treatment Report Years Considered
Figure 11. Global Congenital Neutropenia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Congenital Neutropenia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Congenital Neutropenia Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Congenital Neutropenia Treatment Market Share by Regions (2022-2027)
Figure 15. Global Congenital Neutropenia Treatment Market Share by Players in 2020
Figure 16. Global Top Congenital Neutropenia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Neutropenia Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Congenital Neutropenia Treatment Revenue in 2020
Figure 18. Global Congenital Neutropenia Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Congenital Neutropenia Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Congenital Neutropenia Treatment Market Share by Type (2016-2027)
Figure 22. North America Congenital Neutropenia Treatment Market Share by Application (2016-2027)
Figure 23. North America Congenital Neutropenia Treatment Market Share by Country (2016-2027)
Figure 24. United States Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Congenital Neutropenia Treatment Market Share by Type (2016-2027)
Figure 28. Europe Congenital Neutropenia Treatment Market Share by Application (2016-2027)
Figure 29. Europe Congenital Neutropenia Treatment Market Share by Country (2016-2027)
Figure 30. Germany Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Congenital Neutropenia Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Congenital Neutropenia Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Congenital Neutropenia Treatment Market Share by Region (2016-2027)
Figure 40. China Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Congenital Neutropenia Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Congenital Neutropenia Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Congenital Neutropenia Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Congenital Neutropenia Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Congenital Neutropenia Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Congenital Neutropenia Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Congenital Neutropenia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Baxter International Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 60. Teva Pharmaceutical, Inc. Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 64. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 65. Biogenomics Limited Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 66. Dr. Reddy’s Laboratory Ltd. Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 67. Apotex Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 68. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Congenital Neutropenia Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の顆粒球コロニー刺激因子（G-CSF）薬剤市場規模・現状・予測（2021年-2027年） Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. Market Analysis and Insights: Global Granulocyte-Colony Stimulatin…- 世界の好中球減少症生物学的製剤治療市場規模・現状・予測（2021年-2027年） Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious infections. A neutrophil is a type of white blood cell, which helps in fighting infections. The major causes of neutropenia include cancer chemotherapy,…
- 世界の先天性インスリン過剰症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Congenital Hyperinsulinism Treatment Drugs Market The global Congenital Hyperinsulinism Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
- 顆粒球マクロファージコロニー刺激因子のグローバル市場調査 2019年 The global Granulocyte Macrophage Colony Stimulating Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Granulocyte Macrophage Colony Stimulating Factor volume and value at global level, regiona…
- 世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…